Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex

BACKGROUND: Tamoxifen is currently used for the treatment of both early and advanced estrogen receptor (ER) positive breast cancer in pre- and post-menopausal women. However, using tamoxifen routinely to inhibit endogenous or exogenous estrogen effects is occasionally difficult because of its potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu-Ling, Chen, Chia-Hung, Wu, Hsin-Yi, Tsai, Nu-Man, Jian, Ting-Yan, Chang, Yuan-Ching, Lin, Chi-Hsin, Wu, Chih-Hsiung, Hsu, Fei-Ting, Leung, Ting Kai, Liao, Kuang-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759757/
https://www.ncbi.nlm.nih.gov/pubmed/26892504
http://dx.doi.org/10.1186/s12951-016-0163-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759757/
https://www.ncbi.nlm.nih.gov/pubmed/26892504
http://dx.doi.org/10.1186/s12951-016-0163-3

Ejemplares similares